George A. Scangos, Ph.D. was appointed Chief Executive Officer and a member of the Board of Directors in June 2010. He joined Biogen from Exelixis, Inc., where he served as President and CEO and a director since October 1996. From 1987 to 1996, Dr. Scangos held various positions at Bayer, Inc., including SVP of R&D, and President of Bayer Biotechnology, where he was responsible for research, business development, process development, manufacturing, engineering and quality assurance of Bayer’s recombinant products. Before joining Bayer in 1987, Dr. Scangos was Professor of Biology at Johns Hopkins University. Dr. Scangos has served on a variety of company and non-profit boards, and currently serves on the Board of Directors of Exelixis, Agilent Technologies, the Board of Advisors for the UC Davis School of Medicine, the Board of Trustees for the Boston Museum of Science, and the Board of Directors of the Biomedical Sciences Training Program, which is focused on helping minority and disadvantaged students to have careers in science and medicine. He is also the Chairman-elect of PhRMA. Dr. Scangos received a B.A. in Biology from Cornell University, and a Ph.D. from the University of Massachusetts. He was a Jane Coffin Childs Post-Doctoral Fellow in the laboratory of Dr. Frank Ruddle at Yale University.
George Scangos, PhD